Claudio Semplicini

2.0k total citations
25 papers, 480 citations indexed

About

Claudio Semplicini is a scholar working on Rheumatology, Physiology and Molecular Biology. According to data from OpenAlex, Claudio Semplicini has authored 25 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 12 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Claudio Semplicini's work include Glycogen Storage Diseases and Myoclonus (10 papers), Lysosomal Storage Disorders Research (10 papers) and Muscle Physiology and Disorders (9 papers). Claudio Semplicini is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (10 papers), Lysosomal Storage Disorders Research (10 papers) and Muscle Physiology and Disorders (9 papers). Claudio Semplicini collaborates with scholars based in Italy, France and Denmark. Claudio Semplicini's co-authors include C. Angelini, Elena Pegoraro, Luca Bello, Gianni Sorarú, Francesco Mari, Massimiliano Filosto, Paola Tonin, Sabrina Ravaglia, Pascal Laforêt and Chiara Calore and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Scientific Reports.

In The Last Decade

Claudio Semplicini

25 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Semplicini Italy 17 238 214 185 71 64 25 480
K. Eger Germany 9 156 0.7× 226 1.1× 206 1.1× 53 0.7× 84 1.3× 19 464
Pascal Laforêt France 9 178 0.7× 133 0.6× 118 0.6× 31 0.4× 36 0.6× 18 367
Robert‐Yves Carlier France 12 253 1.1× 135 0.6× 155 0.8× 33 0.5× 103 1.6× 37 546
Dustin Armstrong United States 10 365 1.5× 136 0.6× 116 0.6× 11 0.2× 50 0.8× 12 576
Gilles Morin France 9 158 0.7× 226 1.1× 156 0.8× 60 0.8× 15 0.2× 22 463
N. Strigl‐Pill Germany 6 65 0.3× 361 1.7× 309 1.7× 103 1.5× 31 0.5× 7 456
Carola Hedberg‐Oldfors Sweden 15 335 1.4× 83 0.4× 212 1.1× 6 0.1× 47 0.7× 42 570
Jorge Alonso‐Pérez Spain 10 100 0.4× 82 0.4× 63 0.3× 15 0.2× 48 0.8× 26 250
H. Goebel Germany 13 263 1.1× 108 0.5× 58 0.3× 14 0.2× 53 0.8× 37 475
Anne Chun-Hui Tsai United States 10 153 0.6× 407 1.9× 284 1.5× 86 1.2× 10 0.2× 11 579

Countries citing papers authored by Claudio Semplicini

Since Specialization
Citations

This map shows the geographic impact of Claudio Semplicini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Semplicini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Semplicini more than expected).

Fields of papers citing papers by Claudio Semplicini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Semplicini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Semplicini. The network helps show where Claudio Semplicini may publish in the future.

Co-authorship network of co-authors of Claudio Semplicini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Semplicini. A scholar is included among the top collaborators of Claudio Semplicini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Semplicini. Claudio Semplicini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gregorio, Di, Maddalena Mereu, Gabriella Contarini, et al.. (2022). Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction. Disease Models & Mechanisms. 15(9). 6 indexed citations
2.
Semplicini, Claudio, Marie De Antonio, Nadjib Taouagh, et al.. (2020). Long‐term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry. Journal of Inherited Metabolic Disease. 43(6). 1219–1231. 27 indexed citations
3.
Semplicini, Claudio, Pascal Laforêt, Anthony Béhin, et al.. (2018). The role of electrodiagnosis with long exercise test in mcardle disease. Muscle & Nerve. 58(1). 64–71. 4 indexed citations
4.
Semplicini, Claudio, Marie De Antonio, Nadjib Taouagh, et al.. (2018). Late‐onset Pompe disease in France: molecular features and epidemiology from a nationwide study. Journal of Inherited Metabolic Disease. 41(6). 937–946. 31 indexed citations
5.
Pantic, Boris, Luca Bello, Bruno F. Gavassini, et al.. (2017). SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells. Human Molecular Genetics. 26(17). 3342–3351. 22 indexed citations
6.
Barp, Andrea, Luca Bello, Claudio Semplicini, et al.. (2017). Muscle MRI and functional outcome measures in Becker muscular dystrophy. Scientific Reports. 7(1). 16060–16060. 27 indexed citations
7.
James, M., R. Muni Lofra, Richard Gee, et al.. (2017). North Star Assessment for dysferlinopathy: Longitudinal performance in the clinical outcome study of dysferlinopathy. Neuromuscular Disorders. 27. S145–S145. 1 indexed citations
8.
Bello, Luca, Andrea Barp, Francesco Mari, et al.. (2016). Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies. Scientific Reports. 6(1). 32439–32439. 31 indexed citations
9.
Bertoldo, Francesco, Maurizio Moggio, Valeria Lucchini, et al.. (2015). Prevalence of Asymptomatic Vertebral Fractures in Late-Onset Pompe Disease. Journal of Neuromuscular Diseases. 2(s1). S13–S13. 1 indexed citations
10.
Cao, Michelangelo, Maria Lucia Valentino, Claudio Semplicini, et al.. (2015). Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations. Neurogenetics. 17(1). 65–70. 21 indexed citations
11.
Semplicini, Claudio, John Vissing, Julia R. Dahlqvist, et al.. (2015). Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E. Neurology. 84(17). 1772–1781. 45 indexed citations
12.
Bertoldo, Francesco, Maurizio Moggio, Valeria Lucchini, et al.. (2014). Prevalence of Asymptomatic Vertebral Fractures in Late-Onset Pompe Disease. The Journal of Clinical Endocrinology & Metabolism. 100(2). 401–406. 22 indexed citations
13.
Iaccarino, Leonardo, Elena Pegoraro, Luca Bello, et al.. (2014). Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation. PubMed. 5(3). 87–94. 18 indexed citations
14.
Vianello, Andrea, Claudio Semplicini, Alessandra Concas, et al.. (2013). Enzyme Replacement Therapy Improves Respiratory Outcomes in Patients with Late-Onset Type II Glycogenosis and High Ventilator Dependency. Lung. 191(5). 537–544. 20 indexed citations
15.
Mari, Francesco, et al.. (2013). Clinical phenotype, muscle MRI and muscle pathology of LGMD1F. Journal of Neurology. 260(8). 2033–2041. 21 indexed citations
16.
Semplicini, Claudio & C. Angelini. (2013). Clinical scales for the evaluation of neuromuscular patients. Research Padua Archive (University of Padua). 55–66. 1 indexed citations
17.
Angelini, C., Claudio Semplicini, Sabrina Ravaglia, et al.. (2012). New motor outcome function measures in evaluation of Late‐Onset Pompe disease before and after enzyme replacement therapy. Muscle & Nerve. 45(6). 831–834. 54 indexed citations
18.
Angelini, C. & Claudio Semplicini. (2011). Enzyme Replacement Therapy for Pompe Disease. Current Neurology and Neuroscience Reports. 12(1). 70–75. 32 indexed citations
19.
Manara, Renzo, Valentina Citton, Claudio Semplicini, et al.. (2011). Spinal Cord Herniation: A Missing Piece in the Pathogenesis of Amyotrophic Lateral Sclerosis and Multiple Sclerosis?. Neurodegenerative Diseases. 8(5). 381–385. 2 indexed citations
20.
Angelini, C. & Claudio Semplicini. (2010). Metabolic myopathies: the challenge of new treatments. Current Opinion in Pharmacology. 10(3). 338–345. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Eger Breakdown of academic impact, for papers by Pascal Laforêt Breakdown of academic impact, for papers by Robert‐Yves Carlier Breakdown of academic impact, for papers by Dustin Armstrong Breakdown of academic impact, for papers by Gilles Morin Breakdown of academic impact, for papers by N. Strigl‐Pill Breakdown of academic impact, for papers by Carola Hedberg‐Oldfors Breakdown of academic impact, for papers by Jorge Alonso‐Pérez Breakdown of academic impact, for papers by H. Goebel Breakdown of academic impact, for papers by Anne Chun-Hui Tsai
Rankless by CCL
2026